A rapid yeast-based reverse genetics system reveals SARS-CoV-2 Omicron BA.2.86 variant spreads faster than Omicron JN.1 variant in primary human nasal and bronchial epithelial airway cultures
mBio · 10.06.2026 · 17 (6)
DOI: 10.1128/mbio.00122-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 10.06.2026. Verfasst von Jiayu Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Reverse Genetics, SARS-CoV-2, Epithelial Cells. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health, Cystic Fibrosis Research.
Abstract (Originalsprache)
Since the COVID-19 pandemic, several reverse genetics platforms for SARS-CoV-2 have been established. In general, a plasmid-based reverse genetics system is stable and easy to manipulate, distribute, and store. However, traditional methods for the assembly of a large viral genome in a plasmid rely on natural and artificially engineered restriction sites, which are inefficient, time-consuming, labor-intensive, and frequently not successful. Here, we developed a yeast-based homologous recombination system that allows the assembly of the SARS-CoV-2 genome as a cDNA in a bacterial artificial chromosome (BAC) plasmid in a single step. The entire protocol from cDNA construction to virus rescue is simple, rapid, accurate, highly efficient, and can be completed in 2 weeks. Using this system, we have quickly generated recombinant SARS-CoV-2 (rSARS-CoV-2) WA1, Omicron BA.2.86, and Omicron JN.1 viruses expressing mCherry, green fluorescent protein (GFP), and NanoLuc luciferase (Nluc) reporters. Insertion of these reporter genes does not significantly alter the replication of SARS-CoV-2 in cell culture. We also compared the replication kinetics of rSARS-CoV-2-WA1, BA.2.86, and JN.1 reporter viruses in ex vivo primary human nasal epithelial (HNE) and human bronchial epithelial (HBE) cultures. Omicron BA.2.86 replicated and spread more efficiently than JN.1, which spread much faster than SARS-CoV-2 WA1 in these cultures. In summary, we have developed a highly efficient yeast-based recombinant system for the construction of infectious cDNA clones of SARS-CoV-2, enabling rapid genetic manipulation of SARS-CoV-2. In addition, the reporter viruses generated in this study will be useful for monitoring SARS-CoV-2 infection in vitro and in vivo . IMPORTANCE Reverse genetics systems are an essential tool for probing the biology of viruses, testing antivirals, and developing live-attenuated vaccines. However, it has been a challenge to generate a rapid reverse genetics system for coronaviruses. Here, we developed a rapid, highly efficient reverse genetics system for SARS-CoV-2 that uses yeast homologous recombination. In this procedure, overlapping DNA fragments encompassing the entire SARS-CoV-2 and BAC plasmid fragments containing a yeast replication origin were mixed and transformed into yeast cells to assemble infectious cDNA clones in a single step. This system has enabled us to rapidly generate nine SARS-CoV-2 viruses: WA1, Omicron BA.2.86, and JN.1 viruses each expressing one of three reporters for tracking virus infection in vitro and in vivo . This method is easy, convenient, and highly efficient, generating infectious cDNA clones within 2 weeks. This system could readily be adapted to construct infectious cDNA clones for other large RNA viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA.
- Center for Microbe and Immunity Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
- Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
- Infectious Disease Institute, The Ohio State University, Columbus, Ohio, USA.
- Center for RNA Biology, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Mark E Peeples, Jianrong Li
Förderung
- NIH HHS
- National Institutes of Health
- Cystic Fibrosis Research
Zitieren
APA
Xu, J., Chamblee, M., Hsu, C. C., Jiang, F., Chen, P., Zhang, Y., Liang, X., Amer, A. O., Boyaka, P. N., Cormet-Boyaka, E., Peeples, M. E., & Li, J. (2026). A rapid yeast-based reverse genetics system reveals SARS-CoV-2 Omicron BA.2.86 variant spreads faster than Omicron JN.1 variant in primary human nasal and bronchial epithelial airway cultures. mBio, 17(6). https://doi.org/10.1128/mbio.00122-26
Vancouver
Xu J, Chamblee M, Hsu CC, Jiang F, Chen P, Zhang Y, et al. A rapid yeast-based reverse genetics system reveals SARS-CoV-2 Omicron BA.2.86 variant spreads faster than Omicron JN.1 variant in primary human nasal and bronchial epithelial airway cultures. mBio. 2026;17(6). doi:10.1128/mbio.00122-26
BibTeX
@article{Xu2026,
author = {Xu, Jiayu and Chamblee, Michelle and Hsu, Cheng Chih and Jiang, Fei and Chen, Phylip and Zhang, Yuexiu and Liang, Xueya and Amer, Amal O and Boyaka, Prosper N and Cormet-Boyaka, Estelle and Peeples, Mark E and Li, Jianrong},
title = {A rapid yeast-based reverse genetics system reveals SARS-CoV-2 Omicron BA.2.86 variant spreads faster than Omicron JN.1 variant in primary human nasal and bronchial epithelial airway cultures},
journal = {mBio},
year = {2026},
volume = {17},
number = {6},
doi = {10.1128/mbio.00122-26}
}
EUVIMED